TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Scius Pharma Support AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
73
|
89
|
137 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-26
|
6
|
45 |
| EBITDA |
-26
|
6
|
45 |
| Total assets |
94
|
143
|
185 |
| Current assets |
94
|
143
|
185 |
| Current liabilities |
11
|
8
|
16 |
| Equity capital |
83
|
134
|
169 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
88.3%
|
93.7%
|
91.4% |
| Turnover per employee |
73
|
89
|
137 |
| Profit as a percentage of turnover |
-35.6%
|
6.7%
|
32.8% |
| Return on assets (ROA) |
-27.7%
|
4.2%
|
24.3% |
| Current ratio |
854.5%
|
1787.5%
|
1156.2% |
| Return on equity (ROE) |
-31.3%
|
4.5%
|
26.6% |
| Change turnover |
-16
|
-37
|
59 |
| Change turnover % |
-18%
|
-30%
|
76% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.